Dr. Benjamin Cook -- Pharmaceutical Payment Report
This page provides a comprehensive transparency report for Dr. Benjamin Cook, a Cardiology physician based in Ann Arbor, MI. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Benjamin Cook has received $2,645.54 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.
Physician Profile
The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.
- Full Name: Dr. Benjamin Cook
- Medical Specialty: Cardiology
- Practice Location: Ann Arbor, MI, Michigan
- NPI Number: 1348753658
- Transparency Score: 50/100
- Payment Records Span: 2024-07-18 to 2024-07-18
Payment Summary
Dr. Benjamin Cook has received a total of $2,645.54 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $2,645.54 per transaction.
- Total Payments Received: $2,645.54
- Number of Transactions: 1
- Average Payment: $2,645.54
- Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Cardiology. A higher score indicates fewer or more routine payments.
- Number of Pharma Relationships: 1 pharmaceutical companies
- Drugs/Devices Referenced: 1 distinct products
Payment Breakdown by Category
The following table shows how Dr. Benjamin Cook's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.
| Payment Category | Amount | Description |
|---|---|---|
| Travel & Lodging | $2,645.54 | Transportation and hotel expenses for conferences and meetings |
The largest payment category for Dr. Benjamin Cook is Travel & Lodging, accounting for 100% ($2,645.54) of total pharmaceutical payments received. This represents the primary type of financial relationship between Dr. Benjamin Cook and pharmaceutical companies.
Pharmaceutical Company Relationships
The following pharmaceutical and medical device companies have made payments to Dr. Benjamin Cook. Click on any company name to view their full physician payment profile and spending patterns.
| Company | Total Paid | Transactions |
|---|---|---|
| Pfizer Inc | $2,645.54 | 1 |
Dr. Benjamin Cook has a financial relationship with Pfizer Inc, receiving $2,645.54 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.
Drugs and Medical Devices Referenced in Payments
The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Benjamin Cook. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.
- Trulicity -- Referenced in payment records from pharmaceutical companies to Dr. Benjamin Cook
The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.
AI Transparency Analysis
The following analysis was generated by artificial intelligence based on Dr. Benjamin Cook's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.
Dr. Benjamin Cook, a cardiologist in Ann Arbor, MI, has a pharmaceutical payment profile characterized by a single, recent transaction totaling $2,645.54 from Pfizer Inc. This payment, designated for travel in July 2024, represents the entirety of his reported payments from the pharmaceutical industry. When compared to the average payment volume for cardiologists, Dr. Cook's total is exceptionally low. The cardiology field, like many medical specialties, often sees physicians engage in various forms of collaboration with pharmaceutical companies, which can include consulting, speaking engagements, research, and educational activities. These collaborations, while sometimes substantial, are typically spread across multiple companies and payment types. The fact that Dr. Cook's sole reported payment is from Pfizer Inc. for travel suggests a specific, limited engagement rather than a broad or ongoing relationship. The payment type, travel, is a common category within pharmaceutical interactions, often associated with attending conferences, educational events, or advisory board meetings. This pattern, with a single payment of this nature, does not inherently suggest routine professional activity that warrants significant concern. Instead, it points to a very minimal level of financial interaction with the pharmaceutical industry. For patients, understanding these payments is crucial for maintaining trust and informed decision-making. While a single travel payment is unlikely to directly influence day-to-day clinical decisions or prescribing habits, it's part of a larger transparency initiative. Patients should be aware that even small payments exist and that the vast majority of a doctor's clinical decisions are driven by patient needs, evidence-based medicine, and professional judgment, not by pharmaceutical inducements. The low volume of payments for Dr. Cook suggests a doctor who largely operates independently of significant pharmaceutical funding, which can be reassuring for patients seeking unbiased medical advice. However, it is always prudent for patients to maintain open communication with their healthcare providers about any potential conflicts of interest, however minor.
Patient Guidance: Questions to Ask Your Doctor
If Dr. Benjamin Cook is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:
When considering your doctor's relationship with pharmaceutical companies, it's helpful to approach the information with a balanced perspective. Dr. Cook's profile shows a very low volume of payments, with a single travel expense reported. This is generally a positive indicator of minimal financial ties. However, it's always wise to maintain open communication. At your next appointment, you might consider asking: 'Are there any potential conflicts of interest I should be aware of regarding my treatment options?' or 'How do you stay updated on the latest medical advancements and treatments?' Red flags to watch for include a doctor who consistently prescribes a narrow range of medications from a single manufacturer, especially if newer or more expensive alternatives exist. While occasional payments for travel to educational conferences or for consulting are common and often legitimate ways for doctors to stay informed, a pattern of frequent, high-value payments, particularly for speaking or consulting, might warrant closer scrutiny. Remember, most doctors prioritize patient well-being. These payments are a matter of transparency, not necessarily a direct indicator of compromised care. Evaluate your doctor's overall practice, their communication style, and whether you feel confident in their recommendations. If you have persistent concerns, discussing them openly or seeking a second opinion is always an option.
Peer Comparison: How Dr. Benjamin Cook Compares to Other Cardiology Physicians
The average annual pharmaceutical payments for cardiologists can range significantly, often from a few thousand dollars to tens of thousands, with some specialists receiving much more through extensive research or consulting roles. Dr. Cook's total payment of $2,645.54 is substantially lower than the typical range observed in cardiology. This places him well below the average, indicating minimal financial engagement with pharmaceutical companies compared to his peers.
Recent Payment Records
The following table shows the most recent pharmaceutical industry payments recorded for Dr. Benjamin Cook in the CMS Open Payments database. Click on any payment to view the full report.
| Company | Amount | Type | Drug/Device | Date | Conflict Level |
|---|---|---|---|---|---|
| Pfizer Inc | $2,645.54 | travel | Trulicity | 2024-07-18 | Not Assessed |
Frequently Asked Questions About Dr. Benjamin Cook's Pharma Payments
Below are common questions patients ask about physician pharmaceutical payment data.
Is Dr. Benjamin Cook taking too much pharma money?
Dr. Benjamin Cook's reported pharmaceutical payments are exceptionally low, with a single travel expense of $2,645.54 from Pfizer Inc. This amount is significantly below the average for cardiologists, who often receive payments for various activities like consulting, research, and speaking. His minimal financial interaction suggests he is not heavily influenced by pharmaceutical funding, which can be reassuring for patients seeking unbiased care. The low volume indicates a doctor who largely operates independently of substantial industry financial ties.
What pharma companies pay Dr. Benjamin Cook?
Dr. Benjamin Cook receives payments exclusively from Pfizer Inc. The total amount reported from this company is $2,645.54.
Should I switch doctors because of pharma payments?
Switching doctors solely based on minor pharmaceutical payments is generally not recommended unless you observe a clear pattern of concerning behavior or feel your trust is compromised. Dr. Cook's payment profile is very low. Focus on the quality of care, communication, and your comfort level with your doctor. If you have specific concerns about their prescribing habits or feel their judgment might be influenced, discuss it openly. A single, small payment, especially for travel, is unlikely to be a reason to switch.
What kinds of payments does this doctor receive?
Dr. Benjamin Cook has received one payment categorized as 'travel' from Pfizer Inc., totaling $2,645.54. There are no reported payments for consulting, speaking, meals, research, or ownership interests.
How do these payments compare to other Cardiology?
Dr. Cook's total payment of $2,645.54 is considerably lower than the average for cardiologists. While averages vary, many cardiologists receive significantly more through various engagements. This indicates Dr. Cook has minimal financial ties to the pharmaceutical industry compared to his peers.
Do pharma payments affect prescribing quality?
Research on the impact of pharmaceutical payments on prescribing quality is complex. Some studies suggest even small payments can subtly influence prescribing habits. However, many factors influence prescribing, including patient needs, clinical guidelines, and physician experience. Dr. Cook's minimal payments suggest a lower likelihood of significant influence, but it's always wise to discuss treatment options and alternatives with your doctor.
How can I verify this payment data?
You can verify this payment data directly through the Centers for Medicare & Medicaid Services (CMS) Open Payments database. Visit the official CMS Open Payments website, search for 'Dr. Benjamin Cook' using his NPI (1348753658), and review the reported payments. This database provides detailed information on financial relationships between healthcare providers and the pharmaceutical/medical device industries.
Understanding This Doctor Payment Report
This transparency report for Dr. Benjamin Cook is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:
- Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
- Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
- Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Cardiology physicians may have very different payment norms than physicians in other fields.
- Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
- Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.
About the Physician Payments Sunshine Act
The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.
Under this law, Dr. Benjamin Cook's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.
The Open Payments data for Dr. Benjamin Cook and all other physicians can be accessed at the official CMS Open Payments website.
Related Resources
- Cardiology Specialty Payment Data -- See payment patterns for all cardiology physicians
- Michigan Physician Payments -- Browse pharmaceutical payments to physicians in Michigan
- Cardiology Physicians in Michigan -- Compare Dr. Benjamin Cook to peers in the same state and specialty
- Pfizer Inc Payment Profile -- View all payments made by Dr. Benjamin Cook's largest pharmaceutical partner
- Search for Another Doctor or Company -- Look up any physician or pharmaceutical company in our database
- Official CMS Open Payments Database -- Verify payment data directly with the federal government
- NPI Registry -- Look up Dr. Benjamin Cook's NPI (1348753658) in the official provider registry
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.